Disseminated Nocardiosis: Poorly Controlled Diabetes as an Immunocompromising State

Nocardia species are environmental pathogens that cause rare infections, primarily affecting immunocompromised individuals. These infections can present as pulmonary, cutaneous, or disseminated diseases, often involving the central nervous system. The most common portal of entry is via inhalation or skin breakdown; it is often found in soil, water, and vegetable matter. While typically associated with organ transplantation, malignancy, and immunosuppressive therapy, this case highlights how poorly controlled diabetes may also function as an immunocompromised state, therefore increasing susceptibility to severe Nocardia infections.  We present a case of a 74-year-old man with poorly controlled type two diabetes mellitus (T2DM) with a hemoglobin A1c (HbA1c) greater than 8% who developed a diffuse vesicular rash, altered mental status, and generalized muscle aches. During hospitalization, imaging revealed bilateral lung nodules with cavitation and focal brain enhancement. He was initially treated for a disseminated varicella-zoster virus infection. However, further infectious workup, including molecular testing and tissue culture, confirmed Nocardia infection. The patient demonstrated significant clinical improvement with intravenous trimethoprim-sulfamethoxazole (TMP-SMX) and was discharged on a prolonged course of oral antibiotics.  This case focuses on uncontrolled diabetes as a potential immunocompromising condition that may increase the risk of Nocardia infection. The initial misdiagnosis underscores the diagnostic challenges of this rare disease, particularly in patients without overt immunosuppression. Given the rising global prevalence of diabetes, clinicians should maintain a broad differential when evaluating diabetic patients with systemic illness and unexplained neurological symptoms. Early recognition and targeted treatment of nocardiosis can prevent severe complications, including central nervous system involvement.